Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...

EMBL-EBI scientists and collaborators at Heidelberg University have developed CORNETO, a new computational tool that uses ...

VISTA, an AI-controlled data loop system, guides large-scale antibody design from scratch for applications in cancer therapy.

Monoclonal antibodies are fundamental to modern biomedical research, therapeutic development, and diagnostic applications.

Boehringer Ingelheim says the strongest R&D pipeline in its history is set to deliver 25 new product launches between now and 2030.